Japan is the second-largest pharmaceutical market in Asia and the third largest globally, after the United States and China, accounting for about 7% of the global market share. By participating in this exhibition, we not only gain access to the latest industry trends and technological advancements but also engage in in-depth face-to-face discussions with our clients, reaching cooperation intentions and laying the foundation for further expansion into new markets.